✦ LIBER ✦

Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes

✍ Scribed by Klaus Kølendorf; Johan Eriksson; Kåre I Birkeland; Thomas Kjellström; Astradur B Hreidarsson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD2-2 Efficacy and safety of repaglinide

✍ Guang-wei Li; Wei-ping Jia; Chang-yu Pan; Xiao-hui Guo; Da-jin Zou 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Comparison of vildagliptin and pioglitaz

✍ G. Bolli; F. Dotta; L. Colin; B. Minic; M. Goodman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Glycemic control with Humalog® Mix25™ in

✍ Paris Roach; Ekaterina Koledova; Stephen Metcalfe; Cheryl Hultman; Zvonko Milice 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 889 KB

Single- and multiple-dose pharmacokineti

✍ S. Schumacher; I. Abbasi; D. Weise; V. Hatorp; K. Sattler; J. Sieber; C. Hasslac 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 112 KB

Single- and multiple-dose pharmacokineti

✍ Sabine Schumacher; Isabelle Abbasi; Dagmar Weise; Kristin Sattler; MarkusLeyck D 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Effects of vildagliptin on glucose contr

✍ A. J. Garber; J. E. Foley; M. A. Banerji; P. Ebeling; S. Gudbjörnsdottir; R.-P. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB